The principles of information processing, revealed by our work, deviate from the scientific dogmas adopted by the traditional investigators who study Alzheimer's and Parkinson's diseases. These investigators created significant barriers to the progression of our work.
Therefore, we decided to turn to the families and individuals afflicted by these disorders to ask for their support in developing potentially life-changing treatments for these conditions. This is how Cognistrata Inc. was born.
We are trying to raise $250,000 which will allow us in the next year to identify all signaling components of the brain network. With additional funding, in following years, we will be able to identify the critical components in the brain network which break down early on in AD, PD and drug addictions.
Therefore, we decided to turn to the families and individuals afflicted by these disorders to ask for their support in developing potentially life-changing treatments for these conditions. This is how Cognistrata Inc. was born.
We are trying to raise $250,000 which will allow us in the next year to identify all signaling components of the brain network. With additional funding, in following years, we will be able to identify the critical components in the brain network which break down early on in AD, PD and drug addictions.
